MedPath

Isoleucine

Generic Name
Isoleucine
Brand Names
Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
Drug Type
Small Molecule
Chemical Formula
C6H13NO2
CAS Number
73-32-5
Unique Ingredient Identifier
04Y7590D77

Overview

An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.

Background

An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.

Indication

The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code
INTRAVENOUS
255 mg in 100 mL
2021/04/13
0338-1091
INTRAVENOUS
0.49 g in 100 mL
2022/08/04
0338-1131
INTRAVENOUS
300 mg in 100 mL
2021/04/13
0338-1101
Baxter Healthcare Company
INTRAVENOUS
300 mg in 100 mL
2020/09/21
0338-1148
Baxter Healthcare Company
INTRAVENOUS
480 mg in 100 mL
2020/09/21
0338-0214
INTRAVENOUS
164 mg in 100 mL
2023/08/02
63323-712
INTRAVENOUS
360 mg in 100 mL
2021/04/13
0338-0198
INTRAVENOUS
1.08 g in 100 mL
2020/10/07
0338-0499
INTRAVENOUS
600 mg in 100 mL
2017/11/16
0338-0644
INTRAVENOUS
749 mg in 100 mL
2018/06/01
0338-0502

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date
HK-59165
Part 1, Schedule 1 & Schedule 3 Poison
POM
2010/01/28
HK-36470
Part 1, Schedule 1 & Schedule 3 Poison
POM
1992/10/14
HK-62246
Part 1, Schedule 1 & Schedule 3 Poison
POM
2013/10/24
HK-60999
b. braun medical (hk) ltd
Part 1, Schedule 1 & Schedule 3 Poison
POM
2012/01/11
HK-60482
Part 1, Schedule 1 & Schedule 3 Poison
POM
2011/05/26
HK-61206
otsuka pharmaceutical (h.k.) limited
Part 1, Schedule 1 & Schedule 3 Poison
POM
2012/04/05
HK-06059
luen cheong hong ltd
Part 1, Schedule 1 & Schedule 3 Poison
POM
1979/05/17
HK-61000
b. braun medical (hk) ltd
Part 1, Schedule 1 & Schedule 3 Poison
POM
2012/01/11
HK-62100
wings pharmaceutical ltd
Part 1, Schedule 1 & Schedule 3 Poison
POM
2013/08/15
HK-62890
Non-Poison
OTC
2014/06/06
© Copyright 2025. All Rights Reserved by MedPath